Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Bradykinin Receptor

The bradykinin receptor family is a group of G-protein coupled receptors whose principal ligand is the protein bradykinin. There are two Bradykinin receptors: the B1 receptor and the B2 receptor.

  • Sar-[D-Phe8]-des-Arg9-Bradykinin acetate
    TP1917L1
    Sar-[D-Phe8]-des-Arg9-Bradykinin acetate is a potent and selective bradykinin B1 receptor agonist (EC50 = 9.02 nM in rabbit aorta) that is resistant to aminopeptidase, kininase I and II (ACE) and neutral endopeptidase cleavage. Exhibits hypotensive and angiogenic activity in vivo.
    • $308
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Anatibant 2HCl
    T26627L209788-45-4In house
    Anatibant 2HCl is a small molecule bradykinin B2 receptor antagonist for the treatment of neurological disorders and may be used in the study of brain injury.
    • $350
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Lys-[Des-Arg9]Bradykinin acetate
    TP1918L1
    Lys-[Des-Arg9]Bradykinin acetate is an endogenous potent and highly selective bradykinin B1 receptor agonist (Ki values are 0.12 and > 30000 nM at human B1 and B2 receptors respectively). Hypotensive agent that reduces peripheral vascular resistance in vivo. 16-fold more potent than [Des-Arg9]-Bradykinin.
    • $81
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • 5-Hydroxy-1-methylhydantoin
    T2822284210-26-4
    5-Hydroxy-1-methylhydantoin (HD-003) is an antioxidant potentially for the treatment of renal failure. A creatinine metabolite, 5-Hydroxy-1-methylhydantoin , a hydroxyl radical scavenger, has previously been shown to confer renoprotection by inhibiting the progression of chronic kidney disease in rats. 5-Hydroxy-1-methylhydantoin is a novel anti-oxidant drug completely suppressed the expression of B2-kinin receptors (B2KR) in response to high glucose (25 mM) stimulation in VSMC and was also shown to attenuate the effects of BK on VSMC remodeling. 5-Hydroxy-1-methylhydantoin inhibited the BK-induced increase in MAPK phosphorylation and attenuated the increase in connective tissue growth factor (CTGF) protein levels in VSMC. These findings suggest that 5-Hydroxy-1-methylhydantoin may confer vascular protection against high glucose concentrations and BK-stimulation to ameliorate vascular injury and remodeling through its anti-oxidant properties.
    • $148
    In Stock
    Size
    QTY
  • R715 TFA(185052-09-9 free base)
    TP1933
    R715 TFA(185052-09-9 free base) is a potent and selective bradykinin B1 receptor antagonist (pA2 = 8.49). Displays no activity at B2 receptors. Reduces mechanical hypernociception in a mouse model of neuropathic pain. Metabolically stable.
    • $152
    In Stock
    Size
    QTY
  • Lys-Bradykinin acetate(342-10-9 free base)
    TP2268L84640-50-6
    Lys-Bradykinin acetate is an endogenous bradykinin receptor agonist.
    • $98
    In Stock
    Size
    QTY
  • Bradykinin (acetate)
    T216106846-03-3
    Bradykinin (acetate) is an active peptide that is generated by the kallikrein-kinin system. It is a inflammatory mediator and also recognized as a neuromediator and regulator of several vascular and renal functions. Enzymatically produced from kallidin in the blood, it is a powerful vasodilator that causes smooth muscle contraction, and may mediate inflammation. It has a role as a human blood serum metabolite and a vasodilator agent. It is a tautomer of a bradykinin(2+).
    • $37
    In Stock
    Size
    QTY
  • [Des-Arg9]-Bradykinin TFA
    T8809199433-70-0
    [Des-Arg9]-Bradykinin is an agonist of Bradykinin (B1) receptor that displays selectivity for B1 over B2 receptors.
    • $50
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • (Hyp³)-Bradykinin acetate
    T36442L
    (Hyp³)-Bradykinin acetate is an agonist of bradykinin B2 receptor and stimulates inositol phosphate production in cultured human fibroblasts.
    • $79
    In Stock
    Size
    QTY
  • MK-0686
    T334211159193-97-1In house
    MK-0686 is an orally available bradykinin B1 receptor antagonist with potential anti-inflammatory activity.
    • $191
    In Stock
    Size
    QTY
  • Safotibant
    T34485633698-99-4In house
    Safotibant (LF-22-0542) is a bradykinin B1 receptor antagonist with anti-inflammatory and analgesic activity for the topical treatment of diabetic macular edema.
    • $146
    In Stock
    Size
    QTY
  • Bombinakinin M acetate
    TP2075L
    Bombinakinin M acetate is a potent bradykinin receptor agonist with high selectivity for mammalian arterial smooth muscle bradykinin receptors and is approximately 50 times more potent than bradykinin.
    • $327
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Lys-[Des-Arg9]Bradykinin,TFA
    TP1918L
    Lys-[Des-Arg9]Bradykinin,TFA is Endogenous potent and highly selective bradykinin B1 receptor agonist (Ki values are 0.12 and > 30000 nM at human B1 and B2 receptors respectively). Hypotensive agent that reduces peripheral vascular resistance in vivo. 16-fold more potent than [Des-Arg9]-Bradykinin.
    • $79
    In Stock
    Size
    QTY
  • B-Raf IN 14
    T72070326918-98-3
    B-Raf IN 14 is a BRAF inhibitor.
    • $195
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • NPC 567 acetate
    T21060L
    NPC 567 acetate is a bradykinin B2 antagonist and can be used in studies about the treatment of allergic airway disease.
    • $195
    In Stock
    Size
    QTY
  • Bradykinin
    TP127758-82-2
    Bradykinin is an inflammatory mediator. It is a peptide that causes blood vessels to dilate (enlarge) via the release of prostacyclin, nitric oxide, and Endothelium-Derived Hyperpolarizing Factor. Bradykinin is a physiologically and pharmacologically active peptide of the kinin group of proteins, consisting of nine amino acids.
    • $58
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Bradykinin (2-9)
    TP118116875-11-9
    Bradykinin (2-9) (Des-Arg1-bradykinin) is an amino-truncated peptide compound that is a metabolite of Bradykinin. It is formed by the cleavage action of Aminopeptidase P.
    • $44
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • [Des-Arg9]-Bradykinin
    T764515958-92-6
    [Des-Arg9]-Bradykinin ([Des-Arg9]-Bradykinin(2TFA))(2TFA) is an agonist of Bradykinin (B1) receptor.
    • $265
    35 days
    Size
    QTY
    TargetMol | Inhibitor Sale
  • ELN-441958
    T2086913064-47-8
    ELN-441958 is a potent, neutral antagonist of B1 receptor, inhibits the binding of the B1 agonist ligand [3H]DAKD to IMR-90 cells with Ki of 0.26 nM. ELN-441958(ELN 441958) is highly selective for B1 over B2 receptors.
    • $93
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • [Des-Arg9]-Bradykinin acetate
    TP144523827-91-0
    [Des-Arg9]-Bradykinin acetate is a selective agonist of Bradykinin B1 receptor.
    • $47
    In Stock
    Size
    QTY
  • Icatibant Acetate
    T22344138614-30-9
    Icatibant Acetate, an antagonist of the bradykinin B2 receptor, is used in the treatment of hereditary angioedema.
    • $64
    In Stock
    Size
    QTY
  • Lys-(Des-Arg9,Leu8)-Bradykinin
    T8011771800-37-8
    Lys-(Des-Arg9,Leu8)-Bradykinin is a selective antagonist of the bradykinin B1 receptor [1].
    • Inquiry Price
    Size
    QTY
  • SSR240612
    T5048464930-42-5
    SSR240612 is a potent, and orally active specific non-peptide bradykinin B1 receptor antagonist (Kis = 0.48-0.73 and 358-481 nM for B1 and B2 receptors, respectively).
    • $247
    In Stock
    Size
    QTY
  • Des-Arg9-[Leu8]-Bradykinin acetate
    T80072115035-45-5
    Des-Arg9-[Leu8]-Bradykinin acetate is a potent antagonist of the bradykinin receptor 1 (B1R), utilized in renal fibrosis research [1].
    • Inquiry Price
    Size
    QTY